Zomedica

Ann Arbor, United States Founded: 2015 • Age: 11 yrs
Diagnostics and pharmaceuticals for companion animals are developed.

About Zomedica

Zomedica is a company based in Ann Arbor (United States) founded in 2015.. The company has 152 employees as of December 31, 2024. Zomedica has completed 3 acquisitions, including PulseVet, Revo Squared and Structured Monitoring Products. Zomedica offers products and services including ZOM•Dx and Assisi’s tPEMF Therapy.

  • Headquarter Ann Arbor, United States
  • Employees 152 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Zomedica Corp.
Operational Areas
Healthcare → Veterinary & Animal Health
Key Metrics
  • Annual Revenue
    $27.29 M
    8.33
    as on Dec 31, 2024
  • Net Profit
    $-46.98 M
    -36.07
    as on Dec 31, 2024
  • EBITDA
    $-27.04 M
    -6.91
    as on Dec 31, 2024
  • Latest Funding Round
    $12 M (USD), Post-IPO

    May 30, 2019

  • Investors
  • Employee Count
    152

    as on Dec 31, 2024

  • Investments & Acquisitions
    PulseVet

    & 2 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Zomedica

Zomedica is a publicly listed company on the OTC with ticker symbol ZOMDF in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: OTC · Ticker: ZOMDF . Sector: Health technology · USA

Products & Services of Zomedica

Zomedica offers a comprehensive portfolio of products and services, including ZOM•Dx and Assisi’s tPEMF Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

The diagnostic process is enhanced from sample collection to result analysis using cutting-edge tools.

Therapy is provided to decrease pain, inflammation, and anxiety in animals through revolutionary methods.

People of Zomedica
Headcount 10-50
Employee Profiles 31
Board Members and Advisors 7
Employee Profiles
People
Peter L. Donato
CFO
People
Karen Dehaan-Fullerton
General Counsel & Corporate Secretary
People
Ashley Wood
VP, Research & Development
People
Tony Blair
COO

Unlock access to complete

Board Members and Advisors
people
Pam Nichols
Director
people
Rodney J. Williams
Director
people
Sean Whelan
Director

Unlock access to complete

Funding Insights of Zomedica

  • Total Funding
  • Total Rounds 8
  • Last Round Post-IPO — $12.0M
  • First Round

    (30 Dec 2015)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2019 Amount Post-IPO - Zomedica Valuation

investors

Jun, 2018 Amount Post-IPO - Zomedica Valuation

investors

May, 2018 Amount Post-IPO - Zomedica Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Zomedica

Zomedica has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include PulseVet, Revo Squared and Structured Monitoring Products. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Alternative radio programming and local news content are provided.
2012
Developer of sound wave based device for pain management
2009
Veterinary ultrasound imaging products are manufactured for animal care applications.
2008
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Zomedica

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Zomedica Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Zomedica

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Zomedica

Frequently Asked Questions about Zomedica

When was Zomedica founded?

Zomedica was founded in 2015.

Where is Zomedica located?

Zomedica is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.

Who is the current CEO of Zomedica?

Larry Heaton is the current CEO of Zomedica.

How many employees does Zomedica have?

As of Dec 31, 2024, the latest employee count at Zomedica is 152.

What is the annual revenue of Zomedica?

Annual revenue of Zomedica is $27.29M as on Dec 31, 2024.

What does Zomedica do?

Zomedica was founded in 2015 in Ann Arbor, United States. Diagnostics and pharmaceutical products targeting unmet diseases in companion animals, such as canine, feline, and equine species, are developed. The diagnostics pipeline features point-of-care platforms for thyroid, adrenal, and urinary conditions, along with liquid biopsy for cancer detection. Therapeutic options address diarrhea and hyperthyroidism within the veterinary sector.

What products or services does Zomedica offer?

Zomedica offers ZOM•Dx and Assisi’s tPEMF Therapy.

Is Zomedica publicly traded?

Yes, Zomedica is publicly traded on OTC under the ticker symbol ZOMDF.

How many acquisitions has Zomedica made?

Zomedica has made 3 acquisitions, including PulseVet, Revo Squared, and Structured Monitoring Products.

What is Zomedica's ticker symbol?

The ticker symbol of Zomedica is ZOMDF on OTC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available